Skip to main content
KLRS logo

KLRS · Kalaris Therapeutics, Inc. · Analyst Estimates

Track KLRS — free
$2.02 -0.03 (-1.46%)
Market Cap
$48.80M
Shares
23.80M
Volume · Nov 4 28.26K Avg daily vol (3M) 66.51K

Analyst Estimates

Compare analyst forecasts for Kalaris Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-20 18:02 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-2.08
-2.00
-1.85
8
-2.00
-2.01
-2.01
-2.03
1
1
5
5
Revenue
USD
Publication date not stated
0.00
0.00
0.00
7
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-2.20
-1.65
0.70
8
-1.65
-1.66
-1.66
-1.63
2
2
2
2
Revenue
USD
Publication date not stated
0.00
11.43M
80.00M
7
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.57
-0.52
-0.40
8
-0.52
-0.52
-0.52
-0.52
2
2
4
4
Revenue
USD
Publication date not stated
0.00
0.00
0.00
7
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.59
-0.54
-0.48
8
-0.54
-0.54
-0.54
-0.55
2
2
5
5
Revenue
USD
Publication date not stated
0.00
0.00
0.00
7
— — — — — — — —
Key facts CIK 1754068 CUSIP 482929106 13F (30d) 4 filings 4 filers Visit website Investor relations